Penbrook Management LLC Purchases 90 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Penbrook Management LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,050 shares of the financial services provider’s stock after purchasing an additional 90 shares during the period. Penbrook Management LLC’s holdings in iShares Biotechnology ETF were worth $556,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the company. Miracle Mile Advisors LLC lifted its position in iShares Biotechnology ETF by 1.3% during the 1st quarter. Miracle Mile Advisors LLC now owns 24,854 shares of the financial services provider’s stock worth $3,410,000 after buying an additional 308 shares in the last quarter. Mirador Capital Partners LP increased its holdings in iShares Biotechnology ETF by 3.1% during the first quarter. Mirador Capital Partners LP now owns 28,833 shares of the financial services provider’s stock worth $3,956,000 after buying an additional 860 shares during the last quarter. Chapin Davis Inc. bought a new stake in iShares Biotechnology ETF during the first quarter worth $215,000. SteelPeak Wealth LLC lifted its stake in iShares Biotechnology ETF by 14.2% in the first quarter. SteelPeak Wealth LLC now owns 7,763 shares of the financial services provider’s stock valued at $1,065,000 after acquiring an additional 966 shares during the last quarter. Finally, Toth Financial Advisory Corp grew its position in shares of iShares Biotechnology ETF by 10.1% in the 1st quarter. Toth Financial Advisory Corp now owns 35,433 shares of the financial services provider’s stock valued at $4,862,000 after acquiring an additional 3,246 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.7 %

Shares of IBB stock traded down $0.95 on Tuesday, reaching $136.02. The stock had a trading volume of 1,272,022 shares, compared to its average volume of 1,636,634. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The firm’s 50-day moving average is $134.64 and its two-hundred day moving average is $134.94.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.